Mala Murthy - 28 Feb 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 28 Feb 2025
Net transactions value: -$83,573
Form type: 4
Filing time: 04 Mar 2025, 16:07:06 UTC
Previous filing: 03 Dec 2024
Next filing: 21 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+3,369	+3.6%		96,157	28 Feb 2025	Direct	F1
transaction	TDOC	Common Stock	Options Exercise		+2,044	+2.1%		98,201	28 Feb 2025	Direct	F1
transaction	TDOC	Common Stock	Options Exercise		+7,750	+7.9%		105,951	28 Feb 2025	Direct	F1
transaction	TDOC	Common Stock	Options Exercise		+2,641	+2.5%		108,592	28 Feb 2025	Direct	F2
transaction	TDOC	Common Stock	Sale	$83,573	-8,630	-7.9%	$9.68	99,962	03 Mar 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-3,369	-100%	$0.000000	0	28 Feb 2025	Common Stock	3,369		Direct	F1, F4
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-2,044	-50%	$0.000000	2,044	28 Feb 2025	Common Stock	2,044		Direct	F1, F5
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-7,750	-20%	$0.000000	31,004	28 Feb 2025	Common Stock	7,750		Direct	F1, F6
transaction	TDOC	Performance Stock Units	Options Exercise	$0	-2,641	-20%	$0.000000	10,567	28 Feb 2025	Common Stock	2,641		Direct	F2, F7
transaction	TDOC	Restricted Stock Units	Award	$0	+172,594		$0.000000	172,594	01 Mar 2025	Common Stock	172,594		Direct	F8, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4	On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5	On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6	On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7	On March 1, 2024, the reporting person earned 31,696 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8	Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F9	One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.